Category: 6. Health

The long-acting monoclonal antibody nirsevimab (Beyfortus) protects children younger than 2 years from respiratory syncytial virus (RSV) infection for up to 1 year but may not do so beyond that period, suggests a large real-world study published…

Patients with chronic glomerulonephritis (CGN) experience persistent kidney damage associated with inflammation and may experience proteinuria. Hydroxychloroquine (HCQ) is commonly used for its immunomodulatory properties and is a potential…

While most patients with urticaria in the primary care setting recover quickly, a notable proportion develop chronic urticaria (CU), according to new research published in Clinical & Experimental Allergy.¹

The study identified higher age at…

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto and collaborating institutions revealed in Nature Cell Biology a strategy that helps medulloblastoma, the most prevalent…

An evaluation of noncancer medications used concomitantly with cancer therapies for patients with breast cancer showed that proton pump inhibitors specifically were associated with worse survival outcomes and with an increased risk of grade…

Exercise can help women with advanced breast cancer better…

New study findings conducted by researchers from the Helmholtz Munich Institute for Diabetes Research suggest that maternal factors, including early-life epigenetic influences, could play a protective role in reducing the likelihood for type 1…

An evaluation of non-cancer medications used concomitantly with cancer therapies for patients with breast cancer showed that proton pump inhibitors specifically were associated with worse survival outcomes and with an increased risk of grade…